Article

FDA approves two generic versions of tamsulosin

Teva Pharmaceutical Industries Ltd. and Mylan Inc. have separately announced that they received FDA approval for generic versions of tamsulosin hydrochloride capsules, 0.4 mg, for the treatment of signs and symptoms of BPH.

Teva Pharmaceutical Industries Ltd. and Mylan Inc. have separately announced that they received FDA approval for generic versions of tamsulosin hydrochloride capsules, 0.4 mg, for the treatment of signs and symptoms of BPH.

Related Videos
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.